Literature DB >> 3898945

Upper airway response during bronchoprovocation and asthma attack.

C Shindoh, K Sekizawa, W Hida, H Sasaki, T Takishima.   

Abstract

We measured laryngeal resistance (Rla), upper airway resistance (Ruaw), and lower respiratory resistance below the larynx (Rlrs) during methacholine and histamine provocation in 10 normal and 12 asthmatic subjects. In another 10 asthmatic subjects, Rla was measured during medication for spontaneous asthma attack. The Rla was measured with the low-frequency sound method (see reference 9). Direct measurements of Ruaw and Rlrs were obtained using the 3-Hz forced oscillation technique with a needle inserted below the cricoid cartilage. In normal subjects, Ruaw increased in proportion to the increase in Rlrs during methacholine and histamine provocation. In asthmatic subjects, control Ruaw was higher than the control Ruaw in normal subjects (p less than 0.001) and Ruaw did not change despite an increase in Rlrs during methacholine and histamine provocation. After medication for spontaneous asthma attack, Rla decreased in proportion to the decrease in total respiratory resistance (Rrs). We conclude that in asthmatic subjects, Rla contributes to an increase in Rrs during both the nonspasmodic period and the spontaneous asthma attack but does not do so during bronchoprovocation, probably because the larynx is less sensitive than the lower respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3898945     DOI: 10.1164/arrd.1985.132.3.671

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  2 in total

1.  Laryngeal resistance immediately after panting in asthmatic subjects.

Authors:  M Yanai; T Ohrui; K Sekizawa; H Sasaki; T Takishima
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

2.  The Effects of Hyper- and Hypocapnia on Phonatory Laryngeal Airway Resistance in Women.

Authors:  Amanda I Gillespie; William Slivka; Charles W Atwood; Katherine Verdolini Abbott
Journal:  J Speech Lang Hear Res       Date:  2015-06       Impact factor: 2.297

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.